<VariationArchive VariationID="958162" VariationName="NM_145261.4(DNAJC19):c.51del (p.Phe17fs)" VariationType="Deletion" Accession="VCV000958162" Version="9" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2020-07-16" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="943433" VariationID="958162">
      <GeneList>
        <Gene Symbol="DNAJC19" FullName="DnaJ heat shock protein family (Hsp40) member C19" GeneID="131118" HGNC_ID="HGNC:30528" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="180983709" stop="180989838" display_start="180983709" display_stop="180989838" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="180701496" stop="180707561" display_start="180701496" display_stop="180707561" Strand="-" />
          </Location>
          <OMIM>608977</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_145261.4(DNAJC19):c.51del (p.Phe17fs)</Name>
      <CanonicalSPDI>NC_000003.12:180988181:AAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q26.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="180988182" stop="180988182" display_start="180988182" display_stop="180988182" variantLength="1" positionVCF="180988181" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="180705970" stop="180705970" display_start="180705970" display_stop="180705970" variantLength="1" positionVCF="180705969" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>F17fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_743" sequenceAccession="LRG_743">
            <Expression>LRG_743:g.6593del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_743t1" sequenceAccession="LRG_743t1">
            <Expression>LRG_743t1:c.51del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_743p1" sequenceAccession="LRG_743p1" change="p.Phe17fs">
            <Expression>LRG_743p1:p.Phe17fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.180705972del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.180705972del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.180988184del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.180988184del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_022933.1" sequenceAccession="NG_022933" sequenceVersion="1" change="g.6593del">
            <Expression>NG_022933.1:g.6593del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001190233.2" sequenceAccession="NM_001190233" sequenceVersion="2" change="c.-25del">
            <Expression>NM_001190233.2:c.-25del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145261.4" sequenceAccession="NM_145261" sequenceVersion="4" change="c.51del" MANESelect="true">
            <Expression>NM_145261.4:c.51del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_660304.1" sequenceAccession="NP_660304" sequenceVersion="1" change="p.Phe17fs">
            <Expression>NP_660304.1:p.Phe17fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_033722.2" sequenceAccession="NR_033722" sequenceVersion="2" change="n.185del">
            <Expression>NR_033722.2:n.185del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_033723.1" sequenceAccession="NR_033723" sequenceVersion="1" change="n.223del">
            <Expression>NR_033723.1:n.223del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1715007577" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_145261.4(DNAJC19):c.51del (p.Phe17fs) AND 3-methylglutaconic aciduria type 5" Accession="RCV001231277" Version="9">
        <ClassifiedConditionList TraitSetID="493">
          <ClassifiedCondition DB="MedGen" ID="C1857776">3-methylglutaconic aciduria type 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-27" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-07-16" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16055927</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27928778</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29625556</ID>
        </Citation>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="493" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="108" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">3-methylglutaconic aciduria type 5</ElementValue>
                <XRef ID="MONDO:0012435" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARDIOMYOPATHY, DILATED, WITH ATAXIA</ElementValue>
                <XRef Type="MIM" ID="610198" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MGA, TYPE V</ElementValue>
                <XRef Type="MIM" ID="610198" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">3-methylglutaconic aciduria type V</ElementValue>
                <XRef ID="3-methylglutaconic+aciduria+type+V/7607" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">3 alpha methylglutaconic aciduria type V</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MGA 5</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DCMA</ElementValue>
                <XRef Type="MIM" ID="610198" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MGCA5</ElementValue>
                <XRef Type="MIM" ID="610198" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MGA5</ElementValue>
                <XRef Type="MIM" ID="610198" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12964" />
                <XRef ID="12964" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C5-OH Acylcarnitine, Organic Acidemias, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH-Elevated.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Organic Acidemias: Elevated C5-OH, 2022</CitationText>
              </Citation>
              <XRef ID="66634" DB="Orphanet" />
              <XRef ID="C1857776" DB="MedGen" />
              <XRef ID="MONDO:0012435" DB="MONDO" />
              <XRef Type="MIM" ID="610198" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2738803" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="5880262|MedGen:C1857776" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001403792" DateUpdated="2024-02-20" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29625556</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16055927</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27928778</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 958162). This premature translational stop signal has been observed in individual(s) with clinical features of 3-methylglutaconic aciduria type V (PMID: 29625556). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe17Leufs*10) in the DNAJC19 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAJC19 are known to be pathogenic (PMID: 16055927, 27928778).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DNAJC19" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.180705970del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1857776" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2738803" TraitType="Disease" MappingType="XRef" MappingValue="C1857776" MappingRef="MedGen">
        <MedGen CUI="C1857776" Name="3-methylglutaconic aciduria type 5" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002017307</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

